Webinar Replay: Best Practices to Incorporate Diversity and Inclusion in MedTech

Wach Now On-Demand

The FDA’s recent release of “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials: Guidance for Industry” reflects the increasing importance of implementing a patient-centric approach throughout the product lifecycle. To address the diversity of the US population, sponsors quickly find themselves in a complex ecosystem of patient characteristics that include social determinants of health, mistrust in the medical community and research process, unequal access to care, under-represented and under-diagnosed minority populations, co-morbidity, and more.

Watch this on-demand webinar by Alira Health in partnership with MassMEDIC to get an insight into the topic of diversity and inclusion as it applies across the product lifecycle, identify structural and operational barriers to improved representation, and highlight how technology and decentralized approaches to clinical trials and patient engagement can bridge the gap.


  • Nada Hanafi, SVP Regulatory Strategy, Veranex & Co-Founder and Board Director, MedTech Color
  • Kathleen Troeger, Senior Director, Real-World Evidence, Medical Device and Diagnostics, Aetion
  • Jaime Wheeler, Sr. VP Global Clinical Affairs, Edwards Lifesciences
  • Neely Williams, Community Partner Consultant at NIH, PCORI & PCORnet

The discussion is moderated by Renee Willmon, Senior Director Evidence & Outcomes, Alira Health.

Published on:
July 7, 2022
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.